These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10463288)

  • 41. [DNA ploidy pattern in resected human hepatocellular carcinomas from the view point of biological malignant potential].
    Saiki I; Une Y; Shimamura T; Uchino J
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():135-42. PubMed ID: 8678556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation.
    Fanburg-Smith JC; Meis-Kindblom JM; Fante R; Kindblom LG
    Am J Surg Pathol; 1998 Jul; 22(7):779-94. PubMed ID: 9669341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric DNA analysis of hepatocellular carcinoma.
    Fujimoto J; Okamoto E; Yamanaka N; Toyosaka A; Mitsunobu M
    Cancer; 1991 Feb; 67(4):939-44. PubMed ID: 1846770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Malignancy of hepatocellular carcinoma evaluated with nuclear DNA ploidy pattern].
    Kamiyama T; Uchino J; Une Y; Ishizu H
    Nihon Rinsho; 1992 Oct; 50(10):2408-12. PubMed ID: 1333017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis.
    Yamaguchi A; Ishida T; Takegawa S; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Izumi R; Miyazaki I
    Oncology; 1990; 47(6):478-82. PubMed ID: 2243667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
    Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
    Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic implications of the ploidy pattern of the nuclear DNA in hepatocellular carcinomas].
    Omagari K; Imanishi T; Morikawa S; Nishihata S; Kamiya T; Hayashida K; Tanioka H; Murata I; Makiyama K; Ashihara K
    Gan No Rinsho; 1990 Feb; 36(2):121-6. PubMed ID: 2155330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA ploidy pattern in synchronous and metachronous hepatocellular carcinomas.
    Nagasue N; Kohno H; Chang YC; Yamanoi A; Kimoto T; Takemoto Y; Nakamura T
    J Hepatol; 1992 Sep; 16(1-2):208-14. PubMed ID: 1336508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
    Osterheld MC; Caron L; Meagher-Villemure K
    Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
    Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
    Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
    Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Karlsson M; Seidal T
    Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.